Many lines of evidence demonstrate that TBI survivors experienced cognitive deficits and that TBI animal models recapitulate AD pathological phenotypes, such as increased astrocytes, activated microglia, Aβs levels in the cerebrospinal fluid (CSF) and brain, and formation of Aβs plaques [24–26]. Here, DDX41 is linked to Alzheimer disease.